<p>當美國近一半的公司市盈率（或稱&#34;P/E&#34;）低於 16 倍時，你可能會考慮完全避免投資 <strong>艾可菲</strong>（NYSE:EFX），因為它的市盈率高達 45.7 倍。不過，僅僅根據市盈率來判斷並不明智，因為可能有解釋其如此高的原因。</p>
<p>我們的免費股票報告包含 1 個投資者在投資艾可菲之前應注意的警示信號。現在可以免費閲讀。</p>
<p>艾可菲的盈利增長優於最近大多數其他公司，表現相對良好。似乎許多人預計強勁的盈利表現將持續，這提高了市盈率。如果不是這樣，現有股東可能會對股價的可持續性感到有些緊張。</p>
<p>查看我們對艾可菲的最新分析</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/175749-pe-multiple-vs-industry-1-dark/1745260734664?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/175749-pe-multiple-vs-industry-1-dark/1745260734664"/></p>
<p>NYSE:EFX 市盈率與行業比較 2025 年 4 月 21 日</p>
<p>想要了解分析師對公司的完整預估嗎？那麼我們的 <strong>免費</strong> 艾可菲報告將幫助你揭示未來的趨勢。</p>
<h2>增長指標告訴我們關於高市盈率的什麼？</h2>
<p>為了證明其市盈率的合理性，艾可菲需要實現遠超市場的卓越增長。</p>
<p>回顧過去，我們看到公司去年每股收益增長了 10.0%。然而，遺憾的是，過去三年每股收益總體下降了 21%，這令人失望。因此，可以公平地説，最近的盈利增長對公司來説並不理想。</p>
<p>展望未來，分析師預計在接下來的三年中，每股收益將以每年 28% 的速度增長。這一增長預期顯著高於更廣泛市場的 10% 年增長預測。</p>
<p>鑑於此，艾可菲的市盈率高於大多數其他公司是可以理解的。似乎大多數投資者都在期待這種強勁的未來增長，並願意為該股票支付更高的價格。</p>
<h2>我們可以從艾可菲的市盈率中學到什麼？</h2>
<p>一般來説，我們傾向於將市盈率的使用限制在評估市場對公司整體健康狀況的看法上。</p>
<p>我們已經確定，艾可菲的高市盈率是基於其預測增長高於更廣泛市場的預期。目前，股東對市盈率感到滿意，因為他們相當自信未來的盈利不會受到威脅。除非這些條件發生變化，否則他們將繼續為股價提供強有力的支持。</p>
<p>值得注意的是，我們發現 <strong>艾可菲有 1 個警示信號</strong>，你需要考慮這一點。</p>
<p>當然，<strong>你也可能找到比艾可菲更好的股票</strong>。所以你可能希望查看這份 <strong>免費</strong> 的其他公司集合，這些公司有合理的市盈率並且盈利增長強勁。</p>
<p>如果你打算交易艾可菲，可以在專業人士信任的最低成本平台 Interactive Brokers 開設賬户。</p>
<p>IBKR 在 200 多個國家和地區擁有客户，並可訪問 160 個市場，讓你可以通過一個集成賬户交易股票、期權、期貨、外匯、債券和基金。</p>
<p>享受無隱藏費用、無賬户最低限額，外匯轉換率低至 0.03%，遠低於大多數經紀商提供的費用。</p>
<p>贊助內容</p>

艾可菲

<p>艾可菲公司（NYSE:EFX）的市盈率高達 45.7 倍，遠高於美國平均水平 16 倍，這引發了投資者的擔憂。儘管最近每股收益（EPS）增長了 10%，但該公司在過去三年中每股收益下降了 21%。分析師預測未來三年每股收益年增長率將達到 28%，這為高市盈率提供了合理性。投資者對未來收益保持信心，但存在一個警示信號。建議潛在投資者與其他市盈率合理的公司進行比較</p>

<p>When close to half the companies in the United States have price-to-earnings ratios (or &#34;P/E's&#34;) below 16x, you may consider <strong>Equifax Inc.</strong> (NYSE:EFX) as a stock to avoid entirely with its 45.7x P/E ratio. Although, it's not wise to just take the P/E at face value as there may be an explanation why it's so lofty.</p>
<div class="lb-trans"><p>當美國近一半的公司市盈率（或稱&#34;P/E&#34;）低於 16 倍時，你可能會考慮完全避免投資 <strong>艾可菲</strong>（NYSE:EFX），因為它的市盈率高達 45.7 倍。不過，僅僅根據市盈率來判斷並不明智，因為可能有解釋其如此高的原因。</p>
</div><p>Our free stock report includes 1 warning sign investors should be aware of before investing in Equifax. Read for free now.</p>
<div class="lb-trans"><p>我們的免費股票報告包含 1 個投資者在投資艾可菲之前應注意的警示信號。現在可以免費閲讀。</p>
</div><p>With earnings growth that's superior to most other companies of late, Equifax has been doing relatively well. It seems that many are expecting the strong earnings performance to persist, which has raised the P/E. If not, then existing shareholders might be a little nervous about the viability of the share price.</p>
<div class="lb-trans"><p>艾可菲的盈利增長優於最近大多數其他公司，表現相對良好。似乎許多人預計強勁的盈利表現將持續，這提高了市盈率。如果不是這樣，現有股東可能會對股價的可持續性感到有些緊張。</p>
</div><p>View our latest analysis for Equifax</p>
<div class="lb-trans"><p>查看我們對艾可菲的最新分析</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/175749-pe-multiple-vs-industry-1-dark/1745260734664" alt="" original-src="https://images.simplywall.st/asset/chart/175749-pe-multiple-vs-industry-1-dark/1745260734664"/></p>
<p>NYSE:EFX Price to Earnings Ratio vs Industry April 21st 2025</p>
<div class="lb-trans"><p>NYSE:EFX 市盈率與行業比較 2025 年 4 月 21 日</p>
</div><p>Want the full picture on analyst estimates for the company? Then our <strong>free</strong> report on Equifax will help you uncover what's on the horizon.</p>
<div class="lb-trans"><p>想要了解分析師對公司的完整預估嗎？那麼我們的 <strong>免費</strong> 艾可菲報告將幫助你揭示未來的趨勢。</p>
</div><h2>What Are Growth Metrics Telling Us About The High P/E?</h2>
<div class="lb-trans"><h2>增長指標告訴我們關於高市盈率的什麼？</h2>
</div><p>In order to justify its P/E ratio, Equifax would need to produce outstanding growth well in excess of the market.</p>
<div class="lb-trans"><p>為了證明其市盈率的合理性，艾可菲需要實現遠超市場的卓越增長。</p>
</div><p>Taking a look back first, we see that the company managed to grow earnings per share by a handy 10.0% last year. Still, lamentably EPS has fallen 21% in aggregate from three years ago, which is disappointing. Therefore, it's fair to say the earnings growth recently has been undesirable for the company.</p>
<div class="lb-trans"><p>回顧過去，我們看到公司去年每股收益增長了 10.0%。然而，遺憾的是，過去三年每股收益總體下降了 21%，這令人失望。因此，可以公平地説，最近的盈利增長對公司來説並不理想。</p>
</div><p>Looking ahead now, EPS is anticipated to climb by 28% per annum during the coming three years according to the analysts following the company. That's shaping up to be materially higher than the 10% per year growth forecast for the broader market.</p>
<div class="lb-trans"><p>展望未來，分析師預計在接下來的三年中，每股收益將以每年 28% 的速度增長。這一增長預期顯著高於更廣泛市場的 10% 年增長預測。</p>
</div><p>In light of this, it's understandable that Equifax's P/E sits above the majority of other companies. It seems most investors are expecting this strong future growth and are willing to pay more for the stock.</p>
<div class="lb-trans"><p>鑑於此，艾可菲的市盈率高於大多數其他公司是可以理解的。似乎大多數投資者都在期待這種強勁的未來增長，並願意為該股票支付更高的價格。</p>
</div><h2>What We Can Learn From Equifax's P/E?</h2>
<div class="lb-trans"><h2>我們可以從艾可菲的市盈率中學到什麼？</h2>
</div><p>Generally, our preference is to limit the use of the price-to-earnings ratio to establishing what the market thinks about the overall health of a company.</p>
<div class="lb-trans"><p>一般來説，我們傾向於將市盈率的使用限制在評估市場對公司整體健康狀況的看法上。</p>
</div><p>We've established that Equifax maintains its high P/E on the strength of its forecast growth being higher than the wider market, as expected. Right now shareholders are comfortable with the P/E as they are quite confident future earnings aren't under threat. Unless these conditions change, they will continue to provide strong support to the share price.</p>
<div class="lb-trans"><p>我們已經確定，艾可菲的高市盈率是基於其預測增長高於更廣泛市場的預期。目前，股東對市盈率感到滿意，因為他們相當自信未來的盈利不會受到威脅。除非這些條件發生變化，否則他們將繼續為股價提供強有力的支持。</p>
</div><p>It is also worth noting that we have found <strong>1 warning sign for Equifax</strong> that you need to take into consideration.</p>
<div class="lb-trans"><p>值得注意的是，我們發現 <strong>艾可菲有 1 個警示信號</strong>，你需要考慮這一點。</p>
</div><p>Of course, <strong>you might also be able to find a better stock than Equifax</strong>. So you may wish to see this <strong>free</strong> collection of other companies that have reasonable P/E ratios and have grown earnings strongly.</p>
<div class="lb-trans"><p>當然，<strong>你也可能找到比艾可菲更好的股票</strong>。所以你可能希望查看這份 <strong>免費</strong> 的其他公司集合，這些公司有合理的市盈率並且盈利增長強勁。</p>
</div><p>If you're looking to trade Equifax, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.</p>
<div class="lb-trans"><p>如果你打算交易艾可菲，可以在專業人士信任的最低成本平台 Interactive Brokers 開設賬户。</p>
</div><p>With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.</p>
<div class="lb-trans"><p>IBKR 在 200 多個國家和地區擁有客户，並可訪問 160 個市場，讓你可以通過一個集成賬户交易股票、期權、期貨、外匯、債券和基金。</p>
</div><p>Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.</p>
<div class="lb-trans"><p>享受無隱藏費用、無賬户最低限額，外匯轉換率低至 0.03%，遠低於大多數經紀商提供的費用。</p>
</div><p>Sponsored Content</p>
<div class="lb-trans"><p>贊助內容</p>
</div>

財報揭示了艾可菲公司（NYSE:EFX）的發展歷程